Civic IQ
OTHERONGOING

IBC Meeting Minutes March 19, 2026

Pfizer Clinical Trial Acknowledged By IBC Committee

University Of Massachusetts Medical School WorcesterPFIZERMarch 19, 2026

Trusted by teams at

Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo

Description

The committee acknowledged an ongoing Pfizer-sponsored clinical trial using the Shionogi RSV Protocol v2.0 to evaluate S-337395 in high-risk adults with RSV. Contractual or funding specifics are not detailed in the minutes.

Contract Details

Vendor

PFIZER

Agency

University Of Massachusetts Medical School Worcester, MA

Contract Type

OTHER

Document Date

March 19, 2026

Renewal Info

No information is provided on trial timelines, contract renewals, or extension options for the Pfizer-sponsored study.

Bring us your territory.
We'll show you what is forming.

B2G and SLED sales intelligence. Surface government procurement signals from 80,000+ state, local, and education agencies months before the RFP.

Try Civic IQ for free